The Isoflavanoid (+)-PTC Regulates Cell-Cycle Progression and Mitotic Spindle Assembly in a Prostate Cancer Cell Line

Kaio Moraes de Farias,Rafaela Rosa-Ribeiro,Edmarcia E. Souza,Jorg Kobarg,Martin G. Banwell,Jose Brito Vieira Neto,Sarah Leyenne Alves Sales,Paulo Roberto Ribeiro Costa,Rafael Cavalcante dos Santos,Francisco Vilaca Gaspar,Amaro Gomes Barreto Junior,Maria Conceicao Ferreira Oliveira,Manoel Odorico de Moraes,Cristiana Libardi M. Furtado,Hernandes F. Carvalho,Claudia Pessoa
DOI: https://doi.org/10.1002/cbdv.202200102
2022-01-01
Chemistry & Biodiversity
Abstract:Prostate cancer is the second most common malignancy in men and the development of effective therapeutic strategies remains challenging when more advanced, androgen-independent or insensitive forms are involved. Accordingly, we have evaluated, using flow cytometry, confocal microscopy and image analysis, the anti-proliferative effects of (+)-2,3,9-trimethoxypterocarpan [(+)-PTC, 1] on relevant human prostate cancer cells as well as its capacity to control mitosis within them. In particular, the studies reported herein reveal that (+)-PTC exerts anti-proliferative activity against the PC-3 cell lines by regulating cell-cycle progression with mitosis being arrested in the prophase or prometaphase. Furthermore, it emerges that treatment of the target cells with this compound results in the formation of monopolar spindles, disorganized centrosomes and extensively disrupted gamma-tubulin distributions while centriole replication remains unaffected. Such effects suggest (+)-PTC should be considered as a possible therapy for androgen-insensitive/independent prostate cancer.
What problem does this paper attempt to address?